Stocksigma LogoStocksigma Logo

BharatRohan Achieves Hyperspectral Imaging Milestone for Pharma Quality Screening

BharatRohan Airborne Innovations achieved a technology milestone by applying its proprietary hyperspectral imaging platform to non-destructively detect

BharatRohan Achieves Hyperspectral Imaging Milestone for Pharma Quality Screening

Bharatrohan Airborne Innovations Ltd · Press Release · 13 Nov 2026, 1:33 am

BharatRohan Achieves Hyperspectral Imaging Milestone for Pharma Quality Screening BharatRohan Airborne Innovations achieved a technology milestone by applying its proprietary hyperspectral imaging platform to non-destructively detect adulterated and substandard pharmaceutical tablets across visible and near-infrared spectrums. Extending beyond precision agriculture, the company is engaged in exploratory discussions with Indian regulatory and scientific authorities for potential pilot validation. Management estimates an illustrative global TAM of US$0.8–1.8 billion (India TAM: ~US$100–200 million) and a 3-year global SOM of US$1.5–8 million. Further testing across coatings, packaging, and wider formulations remains ongoing.

Original exchange filing (PDF)

More announcements from Bharatrohan Airborne Innovations Ltd

All Bharatrohan Airborne Innovations Ltd announcements